Today’s Talk Your Book is brought to you by Direxion:
Michael and I had Managing Director and Head of Product Dave Mazza on the show to talk about Direxion ETFs and their new mRNA-focused ETF.
On today’s show we discuss:
- Why the mRNA ETF was needed
- How mRNA was misunderstood
- The threshold to get into the mRNA ETF
- How this thematic ETF can be used
- How to think about investing in biotechs
- Current events affecting the biotech space
- mRNA as a technology, incentives, and curing diseases
Listen here:
Books mentioned:
- Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic
- A Shot to Save the World: The Inside Story of the Life-or-Death Race for a COVID-19 Vaccine
Links:
- The mRNA ETF
- mRNA ETF factsheet
- Direxion spotlight newsletter
- mRNA spotlight newsletter
- Direxion thematic ETFs
Charts:
Follow us on Facebook, Instagram, and YouTube.
Check out our t-shirts, stickers, coffee mugs, and other swag here.
Subscribe here:
